Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trudy N Small

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblingsHugo Castro-Malaspina, Ann A Jabubowski, Esperanza B Papadopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulinAmanda L Olson, Parastoo B Dahi, Junting Zheng, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|September 10, 2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R Wingard, Shelly L Carter, Thomas J Walsh, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Plos Genetics|September 7, 2013
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndromeBari J Ballew, Vijai Joseph, Saurav De, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblingsHugo Castro-Malaspina, Ann A Jabubowski, Esperanza B Papadopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulinAmanda L Olson, Parastoo B Dahi, Junting Zheng, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Blood|September 10, 2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R Wingard, Shelly L Carter, Thomas J Walsh, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Plos Genetics|September 7, 2013
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndromeBari J Ballew, Vijai Joseph, Saurav De, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 4